LI
DGX icon

Louisbourg Investments’s Quest Diagnostics DGX Stock Holding History

Louisbourg Investments’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-136
Closed -$24.4K – 209
2025
Q2 		$24.4K Buy
+136
New +$23.6K 0.01% 141

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Louisbourg Investments's DGX Position: Q3 2025 in Review

Louisbourg Investments sold out of Quest Diagnostics (DGX) in Q3 2025, closing a stake of 136 shares — an estimated $24.4K sold.

Louisbourg Investments first reported a position in DGX in Q2 2025 and held it in 1 quarter. The position peaked at $24.4K in Q2 2025. 1,005 funds tracked by Wall St. Rank hold DGX as of Q3 2025.

  • Louisbourg Investments reported no remaining Quest Diagnostics position as of Q3 2025 after selling out during the quarter.
  • Louisbourg Investments sold 136 Quest Diagnostics shares in Q3 2025, an estimated $24.4K.
  • Louisbourg Investments first reported a position in Quest Diagnostics in Q2 2025 and held it in 1 quarter.
  • Louisbourg Investments's Quest Diagnostics position peaked at $24.4K in Q2 2025.
  • 1,005 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2025.

Based on Louisbourg Investments's 13F filing for Q3 2025, filed 9 Oct 2025.